Company Profile (AI Text)
Name: EMBioSys
Canonical URL: https://wefunder.com/embiosys
Updated at: 2026-10-09T23:53:41Z

Tagline: The Future of Cancer Therapy is Wearable.

Key claims:
- Total raised on Wefunder: 0 | citation: https://wefunder.com/embiosys#claim-total-raised
- Total investors: 0 | citation: https://wefunder.com/embiosys#claim-total-investors

Verified facts:
- Total raised on Wefunder: 0 | observed_at: 2026-10-09T23:53:41Z | expires_at: 2026-10-10T23:53:41Z
- Total investors: 0 | observed_at: 2026-10-09T23:53:41Z | expires_at: 2026-10-10T23:53:41Z

Computed metrics:
- total_amount_raised: 0
- total_investors: 0
- team_size: 5
- featured_investor_count: 1
- faq_count: 0
- recent_post_count: 0

Quick facts:
- Efinia™ is a novel, patented, scalable platform technology representing a large market opportunity | citation: https://wefunder.com/embiosys#claim-fact-1
- $2.65 Million in non-dilutive funding awarded to date from the National Cancer Institute | citation: https://wefunder.com/embiosys#claim-fact-2
- Experienced cross-functional team and business partners | citation: https://wefunder.com/embiosys#claim-fact-3
- Compelling pre-clinical evidence and peer reviewed publications | citation: https://wefunder.com/embiosys#claim-fact-4
- Excellent safety profile: Non-invasive, low power, no adverse events in pre-clinical studies | citation: https://wefunder.com/embiosys#claim-fact-5
- Standard distribution path from demand...to order...to patient | citation: https://wefunder.com/embiosys#claim-fact-6
- Product design & manufacturing activities completed with inventory to support human clinical trials | citation: https://wefunder.com/embiosys#claim-fact-7
- Clear clinical development plan to reach product launch in an area of high unmet medical need | citation: https://wefunder.com/embiosys#claim-fact-8